IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $382 | -4.5% | 39,641 | +5.3% | 0.00% | 0.0% |
| Q2 2023 | $400 | -10.5% | 37,639 | -11.5% | 0.00% | 0.0% |
| Q1 2023 | $447 | -13.4% | 42,529 | +2.1% | 0.00% | -25.0% |
| Q4 2022 | $516 | -99.9% | 41,646 | -8.2% | 0.00% | +33.3% |
| Q3 2022 | $470,000 | +64.9% | 45,368 | +83.4% | 0.00% | +50.0% |
| Q2 2022 | $285,000 | -28.9% | 24,733 | -22.3% | 0.00% | 0.0% |
| Q1 2022 | $401,000 | +12.0% | 31,851 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $358,000 | +11.2% | 30,688 | +24.6% | 0.00% | 0.0% |
| Q3 2021 | $322,000 | +25.3% | 24,624 | +23.4% | 0.00% | +100.0% |
| Q2 2021 | $257,000 | +35.3% | 19,959 | +17.5% | 0.00% | 0.0% |
| Q1 2021 | $190,000 | +20.3% | 16,980 | +22.4% | 0.00% | 0.0% |
| Q4 2020 | $158,000 | -51.8% | 13,877 | -22.0% | 0.00% | -50.0% |
| Q3 2018 | $328,000 | -38.1% | 17,783 | -35.9% | 0.00% | -33.3% |
| Q2 2018 | $530,000 | +20.7% | 27,743 | -2.6% | 0.00% | 0.0% |
| Q1 2018 | $439,000 | -32.9% | 28,469 | -34.7% | 0.00% | -25.0% |
| Q4 2017 | $654,000 | +294.0% | 43,612 | +313.4% | 0.00% | +300.0% |
| Q3 2017 | $166,000 | -13.5% | 10,550 | +3.9% | 0.00% | 0.0% |
| Q2 2017 | $192,000 | -8.1% | 10,152 | -22.8% | 0.00% | 0.0% |
| Q3 2016 | $209,000 | -5.9% | 13,144 | -22.6% | 0.00% | -50.0% |
| Q2 2016 | $222,000 | +29.8% | 16,971 | +8.8% | 0.00% | +100.0% |
| Q1 2016 | $171,000 | +25.7% | 15,596 | +32.9% | 0.00% | 0.0% |
| Q4 2015 | $136,000 | -85.5% | 11,735 | -86.9% | 0.00% | -85.7% |
| Q3 2015 | $935,000 | +1484.7% | 89,686 | +1739.0% | 0.01% | – |
| Q2 2015 | $59,000 | +3.5% | 4,877 | +37.0% | 0.00% | – |
| Q1 2015 | $57,000 | +7.5% | 3,561 | +2.4% | 0.00% | – |
| Q4 2014 | $53,000 | +1.9% | 3,478 | -13.2% | 0.00% | – |
| Q3 2014 | $52,000 | -14.8% | 4,009 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $61,000 | +10.9% | 4,009 | -10.0% | 0.00% | – |
| Q1 2014 | $55,000 | +34.1% | 4,452 | +25.1% | 0.00% | – |
| Q4 2013 | $41,000 | -70.3% | 3,558 | -69.5% | 0.00% | -100.0% |
| Q3 2013 | $138,000 | +119.0% | 11,665 | +84.3% | 0.00% | 0.0% |
| Q2 2013 | $63,000 | – | 6,329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |